Interventions for fatigue in peripheral neuropathy (Q24187233)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article

Language	Label	Description	Also known as
English	Interventions for fatigue in peripheral neuropathy	scientific article

Statements

scholarly article

0 references

0 references

1 reference

Europe PubMed Central

Interventions for fatigue in peripheral neuropathy (English)

0 references

peripheral neuropathy

1 reference

based on heuristic

inferred from title

Rachel C Stockley

object named as

Rachel C Stockley

4

0 references

Pieter A van Doorn

2

object named as

Pieter A van Doorn

0 references

author name string

Claire M White

1

0 references

Marcel PJ Garssen

3

0 references

publication date

18 December 2014

0 references

Cochrane Database of Systematic Reviews

0 references

Amantadine for treatment of fatigue in Guillain-Barre syndrome: a randomised, double blind, placebo controlled, crossover trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008146.PUB2

21 January 2018

Effect of ascorbic acid in patients with Charcot-Marie-Tooth disease type 1A: a multicentre, randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008146.PUB2

21 January 2018

Ascorbic acid in Charcot–Marie–Tooth disease type 1A (CMT-TRIAAL and CMT-TRAUK): a double-blind randomised trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008146.PUB2

21 January 2018

Ascorbic acid for Charcot-Marie-Tooth disease type 1A in children: a randomised, double-blind, placebo-controlled, safety and efficacy trial.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008146.PUB2

21 January 2018

Modafinil reduces fatigue in Charcot-Marie-Tooth disease type 1A: a case series

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008146.PUB2

21 January 2018

Oral high dose ascorbic acid treatment for one year in young CMT1A patients: a randomised, double-blind, placebo-controlled phase II trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008146.PUB2

21 January 2018

Cognitive behavioural therapies for fibromyalgia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008146.PUB2

21 January 2018

Chronic fatigue and chronic fatigue syndrome in the general population

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008146.PUB2

21 January 2018

Exercise for treating fibromyalgia syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008146.PUB2

21 January 2018

Development of a fatigue scale.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008146.PUB2

21 January 2018

Amantadine treatment of fatigue associated with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008146.PUB2

21 January 2018

Exercise for the management of cancer-related fatigue in adults

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008146.PUB2

21 January 2018

Meta-analysis in clinical trials

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008146.PUB2

21 January 2018

Exercise therapy for chronic fatigue syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008146.PUB2

21 January 2018

Meta-analyses involving cross-over trials: methodological issues

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008146.PUB2

21 January 2018

Measuring the functional impact of fatigue: initial validation of the fatigue impact scale.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008146.PUB2

21 January 2018

Construction and validation of a fatigue impact scale for daily administration (D-FIS).

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008146.PUB2

21 January 2018

Physical training and fatigue, fitness, and quality of life in Guillain-Barré syndrome and CIDP.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008146.PUB2

21 January 2018

A prospective study of physiotherapist prescribed community based exercise in inflammatory peripheral neuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008146.PUB2

21 January 2018

Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008146.PUB2

21 January 2018

Medically unexplained physical symptoms, anxiety, and depression: a meta-analytic review

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008146.PUB2

21 January 2018

Measuring inconsistency in meta-analyses

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008146.PUB2

21 January 2018

Fatigue in patients with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008146.PUB2

21 January 2018

Central basis of muscle fatigue in chronic fatigue syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008146.PUB2

21 January 2018

Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008146.PUB2

21 January 2018

Fatigue in multiple sclerosis: definition, pathophysiology and treatment

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008146.PUB2

21 January 2018

Validity and reliability of a scale to assess fatigue

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008146.PUB2

21 January 2018

A quantitative electrophysiological study of acute idiopathic polyneuritis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008146.PUB2

21 January 2018

Fatigue in immune-mediated polyneuropathies. European Inflammatory Neuropathy Cause and Treatment (INCAT) Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008146.PUB2

21 January 2018

Drug therapy for the management of cancer-related fatigue

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008146.PUB2

21 January 2018

A randomized controlled graded exercise trial for chronic fatigue syndrome: outcomes and mechanisms of change

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008146.PUB2

21 January 2018

Disability and quality of life in Charcot-Marie-Tooth disease type 1.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008146.PUB2

21 January 2018

Cognitive behaviour therapy for chronic fatigue syndrome in adults

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008146.PUB2

21 January 2018

Amantadine for fatigue in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008146.PUB2

21 January 2018

Analysis of the electromyographic interference pattern

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008146.PUB2

21 January 2018

Time course of axonal regeneration in acute motor axonal neuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008146.PUB2

21 January 2018

Carnitine for fatigue in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008146.PUB2

21 January 2018

Improving fatigue assessment in immune-mediated neuropathies: the modified Rasch-built fatigue severity scale

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008146.PUB2

21 January 2018

Interventions for fatigue in peripheral neuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008146.PUB2

21 January 2018

Amantadine, fatigue, and multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008146.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008146.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

Activity-dependent hyperpolarization and conduction block in chronic inflammatory demyelinating polyneuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008146.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

Contribution of central and peripheral factors to residual fatigue in Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008146.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

Relative contributions of central and peripheral factors to fatigue during a maximal sustained effort

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008146.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

Activity-dependent conduction block in multifocal motor neuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008146.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

Spinal and supraspinal factors in human muscle fatigue

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008146.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/14651858.CD008146.PUB2

0 references

PubMed publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q24187233&oldid=1633758925"